This article is sponsored by Eyevance Pharmaceuticals, developing innovative and impactful ophthalmic therapies for the ocular surface and anterior segment.
Post Author: Cynthia Matossian, MD and Edward J. Meier, MD
Cynthia Matossian is an ophthalmologist and founder and medical director, Matossian Eye Associates. Edward J. Meier is an ophthalmologist and director, Apex Eye Clinical Research, Cincinnati Eye Institute, Mason, OH. Drs. Matossian and Meier are consultants to Eyevance.
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.